Amanda Alves Nascimento

Amanda Alves Nascimento

Auto-generated profile, based on publicly available information

Amanda Alves Nascimento

Laboratory Neurobiology of the retina, Biology Institute, Department of Neurobiology and Program of Neurosciences Fluminense Federal University Rio de Janeiro Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2024 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
ANA. A. Nascimento
A. A. Nascimento
DPD. Pereira‐Figueiredo
D. Pereira‐Figueiredo
VBV. P. Borges‐Martins
V. P. Borges‐Martins
RKRegina Célia Cussa Kubrusly
Regina Célia Cussa Kubrusly
KCKarin Da Costa Calaza
Karin Da Costa Calaza

13 May 2026 in FEBS Open Bio
Verified
Journal Article
Open access
ANAmanda Alves Nascimento
Amanda Alves Nascimento
DPDanniel Pereira‐Figueiredo
Danniel Pereira‐Figueiredo
GDGabriella Grossi de Lima Dias
Gabriella Grossi de Lima Dias
GSGabriel Ferreira dos Santos
Gabriel Ferreira dos Santos
MPMariana Pereira
Mariana Pereira
KCKarin Da Costa Calaza
Karin Da Costa Calaza
Ischemic damage to the retina during development can lead to irreversible neuronal loss, driven in part by excitotoxic mechanisms and energy deprivation. While two‐day caffeine exposure has previously been shown to confer neuroprotection in this context, it remained unclear whether acute administration during an ischemic event could yield similar benefits. In this study, we used an ex vivo model of oxygen and glucose deprivation (OGD) in chick embryo retinas to investigate whether a single, acute dose of caffeine applied during the insult reduces cell death and engages intracellular survival pathways. Results showed a significant reduction in OGD‐induced cytotoxicity by caffeine exposure. However, unlike in the context of chronic exposure, acute caffeine exposure did not increase BDNF expression. Furthermore, antioxidant agents failed to mimic caffeine's protective effects, and acute caffeine exposure did not induce the expression of antioxidant response genes, nor oxidative stress or VEGF expression, suggesting that oxidative stress mitigation is not the primary mechanism for this effect. However, pharmacological antagonism of adenosine A 2A receptors with ZM241385 reproduced the neuroprotective effects of caffeine and reduced extracellular glutamate levels during OGD. These findings indicate that acute caffeine administration protects the developing retina primarily through A 2A receptor antagonism and inhibition of glutamate excitotoxicity, rather than by activating canonical survival signaling pathways. This supports the potential use of caffeine as a rapid neuroprotective agent during acute ischemic events in the immature central nervous system.